Skip to content
Study details
Enrolling now

Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

3ive Labs
NCT IDNCT07017933ClinicalTrials.gov data as of Apr 2026
Target enrollment

124

Study length

about 10 months

Ages

22–85

Locations

4 sites in FL, MI, NC +1

What this study is about

This trial is testing a renal assist device in patients with kidney problems who are having heart surgery. The goal is to see if the device helps protect kidney function during and after surgery, which can improve outcomes for these patients.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Renal assist device

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Incidence of Treatment-Emergent Adverse Events, Mean Peak Percent Change in Serum Creatinine

Secondary: AUC Serum Creatinine, Creatinine Clearance, Critical Care Length of Stay

Body systems

Renal